Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yuichi Yoshida, Keiichi Tozawa, Ryo Koto, Chikako Iwao, YongJin Kim, Lu Ban & Volkan Barut. (2024) Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan. Current Medical Research and Opinion 40:4, pages 723-731.
Read now
Read now
Articles from other publishers (3)
Lamprini Sotiropoulou, Marios Athanasios Loupas, Mary Adamopoulou, Dimitris Athanasiou & Maria Kalogeropoulou. (2023) Economic burden and health-related quality of life in patients with neurofibromatosis type 1 in Greece. Open Health 4:1.
Crossref
Crossref
R. N. Mustafin. (2023) Prospects for diagnostics and treatment of neurofibromatosis type 1 in Russia. Siberian journal of oncology 22:3, pages 119-124.
Crossref
Crossref
Kunihiro Ikuta, Yoshihiro Nishida, Tomohisa Sakai, Hiroshi Koike, Kan Ito, Hiroshi Urakawa & Shiro Imagama. (2022) Surgical Treatment and Complications of Deep-Seated Nodular Plexiform Neurofibromas Associated with Neurofibromatosis Type 1. Journal of Clinical Medicine 11:19, pages 5695.
Crossref
Crossref